Catalyst advises the shareholders of Thompson & Morgan on the sale to BVG Group

Catalyst Corporate Finance has advised the shareholders of Thompson & Morgan Group Holdings (“T&M”), including Primary Capital (“Primary”), on the sale to BVG Group.

Founded in 1855 and based in Ipswich, T&M is the leading horticultural brand in the UK, selling young plants, bulbs, nursery stock plants, flower and vegetable seeds, fruit, potatoes and garden accessories.  It sells through a variety of channels including catalogue, online, retail, readers’ offers & promotions and TV shopping.

Over the course of Primary’s investment, the business has more than doubled in size through steady organic growth and some small acquisitions.  Bryan Magrath was brought in three years ago as CEO to lead the growth of the T&M core seed and plug plants range into complementary garden product areas and was subsequently joined by Mark Logan as CFO.

Commenting on the sale, Peter Jacobs, Partner at Primary who led the original deal and represented T&M’s interests throughout the period of the investment, commented:

“T&M has prospered under the leadership of Bryan Magrath who has helped stimulate revenue opportunities in new product areas, building on T&M’s leading brand and strong customer database.  We are pleased that T&M has been sold to a strategic buyer in BVG Group and wish everyone involved with T&M all the best for the future. Catalyst worked tirelessly to help deliver a successful result for T&M’s shareholders.”

Catalyst Partner Steve Currie, who led the deal supported by Robert Young, commented:

“We were delighted to work with Bryan, Mark and Primary on the sale of T&M. Together, they have created one of the UK’s leading online retailers in the gardening sector. I am sure they have found the right partner in BVG Group and that the business will go from strength to strength.”

< Go back to results
 

Alantra expands its technology sector team with two senior appointments

Alantra has expanded its Technology Media and Telecoms (TMT) sector team with two senior appointments. James Chapman-Andrews joins as Partner and Head of UK TMT and Simon Devonshire OBE, joins as Technology Industry Adviser.  

Alantra advises on sale of 3P Biopharmaceuticals to Keensight Capital

We advised Cinfa and the rest of the shareholders on the sale of 3P Biopharmaceuticals to Keensight Capital, a European growth private equity fund with deep expertise in healthcare. 

Alantra strengthens its pharma sector focus with senior appointment

Alantra has appointed Anthony Harrington as a partner and key member of its healthcare advisory team. A leading advisor to the pharma services sector, Anthony has over 15 years of M&A experience in the healthcare sector.  

Alantra advises Maine Pointe on its partnership with SGS

Alantra advises US-based Maine Pointe on its international investment by SGS, the Swiss-listed, global testing, inspection and certification specialist. 

Alantra advises ECI on its investment in Send For Help

Alantra has advised ECI on its investment in Send For Help, the global leading provider of lone worker protection.